stars 1 stars 2 stars 3

ACDIMA BioCenter for Bioequivalence and Pharmaceutical Studies is one of the multi projects of the Arab Company for Drug Industries and Medical Appliances (ACDIMA) that was founded as a Contract Research Organization (CRO) more than 15 years ago in Amman, Jordan. It employs qualified trained personnel with high level of experience and is well equipped with state of the art bioanalytical and laboratory equipment as well as a modern specialized clinical site.

ACDIMA BioCenter Questions

The ACDIMA BioCenter annual revenue was $9.6 million in 2026.

Rabab Tayyem is the CEO and Executive Director of ACDIMA BioCenter.

66 people are employed at ACDIMA BioCenter.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users